1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow XMT-1522: new trials by email Literature Review of XMT-1522 trials Research Report on XMT-1522
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2 XMT-1522 - Advanced Breast Cancer, Advanced Nonsmall Cell Lung Cancer | Phase 1 | Completed | Mersana Therapeutics | 120 | 2016-11-21 | 2021-02-24 |
United States (1)